Skip to content
Review Open access

Clinical profile, diagnostic challenges, and therapeutic outcome of Mycoplasma pneumoniae -induced rash and mucositis: Case series

Oct 2026 · Journal of Skin and Sexually Transmitted Diseases · pp. 1-6 · 0 citations · 10 references

TL;DR

The clinical spectrum, diagnostic challenges, management, and outcomes of adolescent patients diagnosed with MIRM at a tertiary care center are described, with favourable clinical outcomes, with recurrence seen only in 1 patient during follow-up.

Abstract

Mycoplasma pneumoniae–induced rash and mucositis (MIRM) is a distinct mucocutaneous entity predominantly affecting children and adolescents, characterized by severe mucositis with limited or absent cutaneous involvement following infection with Mycoplasma pneumoniae. The objective of the study was to describe the clinical spectrum, diagnostic challenges, management, and outcomes of adolescent patients diagnosed with MIRM at a tertiary care center. A retrospective review of 10 children diagnosed with MIRM between February 2024 and January 2026 was conducted. Clinical features, laboratory findings, radiological evidence and outcomes were analyzed. The study included 7 males and 3 females aged 10–18 years. Eight patients had preceding respiratory symptoms. The average duration between onset of prodromal respiratory symptoms and development of mucocutaneous lesions was 5.2 days. All patients had mucosal involvement, most commonly oral (90%), genital (80%) and conjunctival (70%). Six patients exhibited limited cutaneous lesions, while two had no skin involvement. Chest imaging revealed lobar or segmental consolidation and bilateral ground-glass opacities in four patients each. The majority of cases were initially misdiagnosed as SJS due to antecedent drug exposure. Following confirmation of M. pneumoniae infection, patients were treated with macrolide antibiotics along with short-term systemic corticosteroids and/or cyclosporine and supportive care. Six patients required systemic corticosteroids, while four patients required additional cyclosporine. All patients showed favourable clinical outcomes, with recurrence seen only in 1 patient during follow-up. Limitations of the study were retrospective design, small sample size and lack of molecular confirmation. MIRM is an underrecognized but distinct mucocutaneous syndrome characterized by prominent mucosal involvement and limited skin disease following M. pneumoniae infection. Awareness of its clinical features and differentiation from Stevens–Johnson syndrome (SJS), erythema multiforme (EM) and reactive infectious mucocutaneous eruptions (RIME) are crucial to prevent misdiagnosis and unnecessary drug avoidance. Early diagnosis and appropriate management result in excellent clinical outcomes.

Read PDF

Similar papers

Nov 2026

Ocular Manifestation of Mycoplasma-Induced Rash and Mucositis: A Case Series of Five Patients.

PURPOSE To characterize the ocular manifestations, management, and outcomes of mycoplasma-induced rash and mucositis (MIRM) in a pediatric population. METHODS Retrospective consecutive case series at a tertiary care pediatric center (Children's Hospital of Eastern Ontario) between July 2023 and October 2024. Inclusio...

Zhao X. Feng, Amir-Ali Golrokhian-Sani, Cody Lo et al. · 0 citations
Open access Oct 2026

Clinico-epidemiological profile of cutaneous tuberculids in a tertiary care hospital: A three-year case series

Cutaneous tuberculids are uncommon hypersensitivity manifestations of Mycobacterium tuberculosis antigen that remain difficult to diagnose due to their varied clinical presentations and paucibacillary nature. This three-year case series evaluated the clinico-epidemiological characteristics, laboratory profile, hist...

Sreeramu Suggu, S. Girada, Sowri Uma Kolaka et al. · 0 citations
Open access Sep 2026

Mycoplasma pneumoniae-induced Rash and Mucositis Mimicking Stevens-Johnson Syndrome in a Four-year-old Child

Mycoplasma pneumoniae-induced rash and mucositis (MIRM) is an infection-related mucocutaneous eruption characterized by severe mucositis at multiple sites with minimal or absent cutaneous involvement. Its clinical presentation may mimic Stevens-Johnson syndrome, making accurate differentiation crucial, especially in pe...

Geon-Jong Lee, Hyunguk Ryu, Kijae Sung et al. · 0 citations
Oct 2026

Mycoplasma-induced mucositis and conjunctivitis: A distinct clinical entity.

Mycoplasma pneumoniae primarily affects the lung, but its extrapulmonary manifestations are less common. We report the case of a 37-year old woman who presented with fever, cough, oral ulcers, and red eyes. There was no skin rash. She showed progression of respiratory symptoms, increased oral ulceration, and worsening...

J. Meher, Shashwat Shukla, Vinay R. Pandit et al. · 0 citations
Open access Sep 2026

Clinical and Laboratory Profile of Mycoplasma pneumoniae Pneumonia among Children Aged 1 Month to 18 Years for 2 Years Admitted in a Tertiary Care Center: A Retrospective Study

To determine proportional morbidity among the children admitted with pneumonia and study clinical, laboratory, radiological findings, management of MP pneumonia (MPP), among hospitalized community-acquired pneumonia (CAP) cases in a tertiary care setting.

Sri Sounderya Yuvaraja Krishnan, Aishwarya Chidhambaram, N. Gowrishankar et al. · 0 citations
Open access Oct 2026

Clinical and laboratory characteristics of mycoplasma pneumonia in children

Objective: to identify clinical, laboratory, and radiological manifestations of mycoplasma pneumonia in children during the period of increased incidence of acute respiratory infections. Materials and methods. The study involved 63 children aged 1—16 years with community-acquired mycoplasma pneumonia who were treated i...

A. Bondarenko · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.